title: NMDA receptor subunit-dependent modulation by conantokin-G and Ala7-conantokin-G.
abstract: The modulation of recombinant NMDA receptors by conantokin-G (con-G) and Ala7-conantokin-G (Ala7-Con-G) was investigated in Xenopus oocytes injected with capped RNA coding for NR1 splice variants and NR2 subunits using the two-electrode voltage clamp technique. Glutamate exhibited a marginally higher apparent affinity for NR2A-containing receptors than NR2B-containing receptors, regardless of the NR1 subunit present. Conantokins were bath applied to give cumulative concentration responses in the presence of 3 and 30 mum glutamate. Both contantokins exhibited biphasic concentration-response relationships at NR2A-containing NMDA receptors, producing potentiation at low conantokin concentrations and inhibition at high concentrations. These effects were stronger with glutamate concentrations near its EC50, and less marked at saturating concentrations. In contrast, the conantokin concentration-response relation was monophasic and inhibitory at NR2B-containing receptors. We conclude that the combinations of subunits that comprise the NMDA receptor complex influence conantokin and glutamate affinities and the nature of the responses to conantokins.
authors.affiliation: School of Molecular and Microbial Sciences, University of Queensland, Brisbane, Queensland, Australia.
authors.forename: L
authors.initials: L
authors.lastname: Ragnarsson
authors.forename: T
authors.initials: T
authors.lastname: Yasuda
authors.forename: R J
authors.initials: RJ
authors.lastname: Lewis
authors.forename: P R
authors.initials: PR
authors.lastname: Dodd
authors.forename: D J
authors.initials: DJ
authors.lastname: Adams
mesh_terms: D000409:Alanine / Q000031:analogs & derivatives / Q000494:pharmacology; D000544:Alzheimer Disease / Q000378:metabolism; D000818:Animals; D003208:Concanavalin A / Q000494:pharmacology; D020916:Conotoxins / Q000494:pharmacology*; D004594:Electrophysiology; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology*; D018698:Glutamic Acid / Q000378:metabolism; D006801:Humans; D008564:Membrane Potentials / Q000502:physiology; D009865:Oocytes / Q000378:metabolism; D018408:Patch-Clamp Techniques; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors*; D011994:Recombinant Proteins / Q000378:metabolism; D014981:Xenopus
chemical_list: C507751:Ala7-conantokin-G; D020916:Conotoxins; D018691:Excitatory Amino Acid Antagonists; C120997:NR2A NMDA receptor; C121001:NR2B NMDA receptor; D016194:Receptors, N-Methyl-D-Aspartate; D011994:Recombinant Proteins; D003208:Concanavalin A; D018698:Glutamic Acid; C055407:conotoxin GV; D000409:Alanine